案例报告:一种新的治疗方法,用于治疗3型氏病的严重间歇性肺病
Vincenza Gragnaniello1,2, Silvia Carraro3, Tiziana Zangardi4
1Division of Inherited Metabolic Diseases, Department of Women's and Children's Health, University of Padova, Padova, Italy.
Frontiers in pediatrics
|June 26, 2025
概括
氏病3型 (GD3) 肺部疾病可能是严重的,即使用酶替代疗法 (ERT). 抗炎药物治疗,如皮质类固醇和氧化,在治疗肺部症状和炎症方面表现有前途.
科学领域:
- 遗传学和罕见疾病.
- 肺部病理学 肺部病理学
- 溶酶体储存障碍 溶酶体储存障碍
背景情况:
- 氏病3型 (GD3) 是一种罕见的溶酶体储存障碍,具有显著的内脏和神经影响.
- 在GD3中肺部的参与可以严重影响患者的预后和生活质量.
- 早期诊断和酶替代疗法 (ERT) 是标准的,但可能不能完全解决所有表现.
关键词:
戈舍氏病是戈舍氏病的一种疾病.皮质类固醇治疗治疗.酶替代疗法是一种酶替代疗法.葡萄糖大脑化酶的使用氧化chloroquine 的使用情况这是一种炎症炎症炎症炎症.间歇性肺病 间歇性肺病新生儿查 新生儿查更多相关视频
相关概念视频
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...